Sustainable access to prescription opioids for use in palliative care

Back to all statements

Sustainable access to prescription opioids for use in palliative care

Thursday, May 09, 2019

A position statement by PCA, also endorsed by other key bodies, including ANZSPM and The Pharmacy Guild of Australia. There is increasing focus on opioid prescribing regulations for chronic pain. In efforts to reduce inappropriate prescribing that can lead to harm from misuse and abuse of opioids, palliative care patients are placed at risk of unintended harm through reduced opioid prescribing. All Australians receiving palliative care must be able to access the necessary opioids to manage and prevent suffering from uncontrolled pain and other symptoms. There is a need to increase understanding of appropriate use of opioids and provide leadership and guidance in resultant regulatory processes for the community and prescribers.

Sustainable access to prescription opioids for use in palliative care

X

Share this article

Select where you would like to share this article

We recognise and acknowledge those who are working through Sorry Business, Sad News, grief and bereavement and offer our condolences and support.

Aboriginal and Torres Strait Islander peoples are advised that this website may contain images, videos and voices of people who have passed on. Some of the content and topics covered might also cause distress. You are welcome here, and we want you to feel safe and take care.

If you find that you need support please reach out to 13YARN on 13 92 76, Grief Australia, Grief Line on 1300 845 745, or Lifeline on 13 11 14.

Palliative Care Australia is located in Canberra. We acknowledge the traditional custodians of the surrounding land and waters, the Ngunnawal and Ngambri Peoples and pay our respects to Elders past and present. We extend that same respect and acknowledge the continuing cultures and contribution of Aboriginal and Torres Strait Islander Peoples across Australia.

Close